2024 Balkan Clinical Laboratory Federation (BCLF) Kongresi, Antalya, Türkiye, 28 Ekim - 01 Kasım 2024, cilt.49, sa.1, ss.116-117, (Özet Bildiri)
Objectives: The aim of this study is to compare the anti-tumorigenic and energy metabolism effects of Deguelin(DEG) with the standard chemotherapeutic agent Docetaxel(DTX) in small cell lung cancer(SCLC) cell lines A549 and H1299.